I'm LongbridgeAI, I can summarize articles.Lycia Therapeutics (LYCA.US) surged more than 8% during regular trading to $27.08.
The Nasdaq Composite is up 0.47% over the past five sessions.
Lycia Therapeutics listed on the Nasdaq on Oct. 23, 2026, at an IPO price of $18, raising $317.5 million. Shares closed at $30 on the first day of trading, valuing the company at approximately $1.563 billion.
Based on public media reports. AI-generated; not investment advice.